About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Solid Tumors Using Ixabepilone and Dasatinib | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT00717704

Solid Tumors Using Ixabepilone and Dasatinib

Patients are being asked to take part in this study because they have been diagnosed with an advanced solid tumor that is not responding to standard treatments. This study will find the highest dose o...

Lead sponsor: Medstar Health Research Institute•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Medstar Health Research Institute

Collaborators

Bristol-Myers Squibb

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Have a solid tumor malignancy that is metastatic or locally advanced/unresectable
•Progression through standard therapy
•Histological documentation of cancer
•Must be off prior chemotherapy or radiation therapy for at least 3 weeks
•Must have adequate organ and marrow function prior to the start of study treatment as defined by the protocol
•Must be able to swallow oral medication (dasatinib must be swallowed whole)
•Must be available for protocol-required follow-up

Exclusion Criteria

•Patients with a malignancy (other than the one treated in this study) which required radiotherapy or systemic therapy within the past 5 years
•Symptomatic brain metastasis that is either untreated or uncontrolled by surgery and or radiotherapy
•A known, prior, severe (NCI CTC Grade 3/Grade 4) history of hypersensitivity reaction to a drug formulated in Cremophor (polyoxyethylated castor oil)
•A serious, uncontrolled medical disorder or active infection including pericardial or pleural effusion of any grade,uncontrolled or significant cardiovascular disease,a bleeding disorder.

Related studies

RECRUITINGPhase 1

Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors

NCT06132828 · Solid Tumor

RECRUITINGPhase 2

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

NCT04570423 · Solid Tumors, Lymphoma

RECRUITINGPhase 1/2

GT201 Injection For The Treatment Of Advanced Solid Tumors

NCT06144671 · Solid Tumor, Adult

NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors

NCT07489378 · Very Rare Tumors, Very Rare Cancers, and more

RECRUITINGPhase 1

A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors

NCT06926283 · Prostate Cancer, Other Solid Tumors, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 5, 2020Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment19

Start dateJul 2008

Last updatedAug 5, 2020

Condition

Locations shown

Washington Cancer Institute

Washington D.C., District of Columbia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 5, 2020Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions